Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Board Changes

3 Feb 2016 07:00

RNS Number : 8684N
Versarien PLC
03 February 2016
 

3 February 2016

 

Versarien plc

("Versarien" or the "Company")

 

Board changes

 

Versarien plc (AIM: VRS), the AIM quoted advanced engineering materials group announces the following changes to its board.

 

Iain Gray CBE has been appointed as an additional non-executive director with immediate effect.

 

Iain has spent his executive career at the highest levels within the aerospace sector, initially with British Aerospace before becoming engineering director of Airbus UK. After 27 years in the sector, Iain was in 2007, appointed Chief Executive of Innovate UK (formerly the Technology Strategy Board) and was responsible for its successful development into an autonomous, independent profit centre looking to drive growth from commercial investment in new areas of technical innovation. He was recently appointed Director of Aerospace at Cranfield University and is a fellow of the Royal Aeronautical Society, the Royal Society of Edinburgh and of the Royal Academy of Engineering.

 

At the same time, Jeremy Veasey will retire as a non-executive director having served on the board since its admission to AIM in 2013.

 

Iain Gilmour Gray, aged 58, is a director of Bristol Aero Collection Trust and Science, Engineering and Manufacturing Technologies Alliance and was within the last five years a director of The Engineering & Technology Board.

 

There is no other information which requires to be disclosed in accordance with paragraph (g) Schedule Two of the AIM Rules for Companies.

 

Commenting on the changes Neill Ricketts, CEO of Versarien, said: "We are very pleased to be welcoming Iain to the Board. With a lengthy career in aerospace and technology, Iain is well placed to help Versarien accelerate its technology commercialisation, especially in 2 dimensional products as well as, bringing his complementary wealth of knowledge and experience to the existing Board.

 

"We would like to thank Jeremy for all of his help over the last few years and wish him well in his retirement."

 

 

For further information please contact:

 

Versarien plc

www.versarien.com

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 888 622

Chris Leigh - Chief Financial Officer

WH Ireland (Nominated Adviser)

www.wh-ireland.co.uk

John Wakefield / Ed Allsopp

+44 (0) 117 945 3470

IFC Advisory (Financial PR and IR)

www.investor-focus.co.uk

Tim Metcalfe / Graham Herring / Heather Armstrong

+44 (0) 20 3053 8671

 

 

Notes to Editors:

Versarien(TM) plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has three subsidiaries:

Versarien Technologies Ltd. which owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals targeting the thermal management industry and manufactures extruded aluminium heat sinks for the electronics and computing industries. www.versarien-technologies.co.uk 

Total Carbide Ltd, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com 

2-DTech Ltd., which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABIGDDLSGBGLD
Date   Source Headline
12th Dec 20249:59 amRNSHolding(s) in Company
11th Dec 20241:21 pmRNSHolding(s) in Company
4th Dec 20247:00 amRNS-RInvestor Presentation
27th Nov 20244:45 pmRNSHolding(s) in Company
26th Nov 20243:42 pmRNSHolding(s) in Company
21st Nov 202411:12 amRNSUpdate on Legal Claims
4th Nov 202412:07 pmRNSHolding(s) in Company
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 202410:36 amRNSUpdate on Sale of Korean Assets
31st Oct 202410:14 amRNSHolding(s) in Company
18th Oct 202410:41 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSPlacing to raise £450,000
4th Oct 20247:00 amRNSCorporate Update
30th Sep 20247:00 amRNSDisposal of AAC Cyroma Limited
14th Aug 20247:00 amRNS3D Construction Printing Contract
5th Aug 20241:16 pmRNSHolding(s) in Company
2nd Aug 202410:48 amRNSUpdate on Sale of Korean Assets
31st Jul 20242:30 pmRNSTotal Voting Rights
29th Jul 20241:47 pmRNSHolding(s) in Company
24th Jul 20247:00 amRNSPlacing to raise £550,000
18th Jul 20247:00 amRNSUpdate on Legal Claims
17th Jul 20247:00 amRNSConversion of Gnanomat Loan
6th Jun 20247:00 amRNSInterim Results for six months ended 31 March 2024
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.